Variant report

Variant	nsv898562
Chromosome Location	chr12:285110-318366
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:719)
CpG islands
(count:1408)
Chromatin interactive
region (count:24)
LncRNA
region (count:11)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:719 , 50 per page) page: 1 2 3 4 5 6 7 ... 15

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr12:298349-298388	K562	blood:	n/a	n/a
2	ATF1	chr12:285620-285967	K562	blood:	n/a	n/a
3	ATF1	chr12:308947-309267	K562	blood:	n/a	n/a
4	ATF3	chr12:289702-289924	K562	blood:	n/a	n/a
5	BACH1	chr12:288438-288716	H1-hESC	embryonic stem cell:	n/a	chr12:288578-288592
6	BACH1	chr12:308502-308715	H1-hESC	embryonic stem cell:	n/a	n/a
7	BACH1	chr12:312656-312881	H1-hESC	embryonic stem cell:	n/a	n/a
8	BHLHE40	chr12:294691-295034	K562	blood:	n/a	chr12:294869-294878 chr12:294870-294879 chr12:294867-294880 chr12:294868-294877 chr12:294869-294878
9	BHLHE40	chr12:294714-295081	HepG2	liver:	n/a	chr12:294869-294878 chr12:294870-294879 chr12:294867-294880 chr12:294868-294877 chr12:294869-294878
10	BHLHE40	chr12:289650-290110	K562	blood:	n/a	n/a
11	BHLHE40	chr12:289673-290107	GM12878	blood:	n/a	n/a
12	BHLHE40	chr12:302513-302839	K562	blood:	n/a	chr12:302670-302679 chr12:302671-302680 chr12:302748-302764 chr12:302671-302680 chr12:302665-302686
13	BHLHE40	chr12:298253-298607	HepG2	liver:	n/a	n/a
14	BHLHE40	chr12:298401-298467	K562	blood:	n/a	n/a
15	BRCA1	chr12:298216-298256	HepG2	liver:	n/a	n/a
16	CCNT2	chr12:298259-298565	K562	blood:	n/a	n/a
17	CEBPB	chr12:299770-300001	HepG2	liver:	n/a	chr12:299932-299943
18	CEBPB	chr12:299833-299960	K562	blood:	n/a	chr12:299932-299943
19	CEBPB	chr12:308999-309199	IMR90	lung:	n/a	n/a
20	CEBPD	chr12:298272-298550	HepG2	liver:	n/a	n/a
21	CHD2	chr12:298159-298475	H1-hESC	embryonic stem cell:	n/a	n/a
22	CHD2	chr12:289744-289944	GM12878	blood:	n/a	n/a
23	CHD2	chr12:291781-291791	H1-hESC	embryonic stem cell:	n/a	n/a
24	CREB1	chr12:312552-312913	A549	lung:	n/a	n/a
25	CREB1	chr12:285466-286175	HepG2	liver:	n/a	n/a
26	CREB1	chr12:285549-286021	GM12878	blood:	n/a	n/a
27	CREB1	chr12:298202-298629	A549	lung:	n/a	n/a
28	CREB1	chr12:285375-286181	HepG2	liver:	n/a	n/a
29	CTBP2	chr12:311109-312144	H1-hESC	embryonic stem cell:	n/a	n/a
30	CTCF	chr12:298440-298590	GM12870	blood:	n/a	n/a
31	CTCF	chr12:308460-308610	HPAF	blood vessel:	n/a	n/a
32	CTCF	chr12:308480-308630	HFF-Myc	foreskin:	n/a	n/a
33	CTCF	chr12:298251-298627	K562	blood:	n/a	chr12:298430-298443 chr12:298428-298446 chr12:298350-298363
34	CTCF	chr12:285779-285804	Pancreas_OC	pancreas:	n/a	n/a
35	CTCF	chr12:298309-298578	LNCaP	prostate:	n/a	chr12:298430-298443 chr12:298428-298446 chr12:298350-298363
36	CTCF	chr12:298400-298550	SAEC	small airway:	n/a	chr12:298430-298443 chr12:298428-298446
37	CTCF	chr12:298172-298614	H1-hESC	embryonic stem cell:	n/a	chr12:298430-298443 chr12:298428-298446 chr12:298350-298363
38	CTCF	chr12:308540-308690	NHEK	skin:	n/a	n/a
39	CTCF	chr12:308480-308630	HCFaa	heart:	n/a	n/a
40	CTCF	chr12:298080-298230	GM12869	blood:	n/a	n/a
41	CTCF	chr12:313000-313150	HMEC	breast:	n/a	chr12:313041-313054 chr12:313038-313056
42	CTCF	chr12:298380-298530	GM12871	blood:	n/a	chr12:298430-298443 chr12:298428-298446
43	CTCF	chr12:313000-313150	HBMEC	blood vessel:	n/a	chr12:313041-313054 chr12:313038-313056
44	CTCF	chr12:298334-298552	HUVEC	blood vessel:	n/a	chr12:298430-298443 chr12:298428-298446 chr12:298350-298363
45	CTCF	chr12:298186-298673	A549	lung:	n/a	chr12:298430-298443 chr12:298428-298446 chr12:298350-298363
46	CTCF	chr12:285260-285410	SK-N-SH_RA	brain:	n/a	n/a
47	CTCF	chr12:298380-298530	GM12870	blood:	n/a	chr12:298430-298443 chr12:298428-298446
48	CTCF	chr12:298380-298530	AG10803	skin:	n/a	chr12:298430-298443 chr12:298428-298446
49	CTCF	chr12:298380-298530	HMEC	breast:	n/a	chr12:298430-298443 chr12:298428-298446
50	CTCF	chr12:298313-298581	LNCaP	prostate:	n/a	chr12:298430-298443 chr12:298428-298446 chr12:298350-298363

(count:1408 , 50 per page) page: 1 2 3 4 5 6 7 ... 29

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:313104-313154	AG04449	skin:	fetal
2	chr12:295951-296001	SK-N-SH	brain:	n/a
3	chr12:299649-299699	NHBE	bronchial:	n/a
4	chr12:300298-300348	NHBE	bronchial:	n/a
5	chr12:316456-316506	NT2-D1	testis:	n/a
6	chr12:313104-313154	AG04449	skin:	fetal
7	chr12:295951-296001	SK-N-SH	brain:	n/a
8	chr12:299649-299699	NHBE	bronchial:	n/a
9	chr12:300298-300348	NHBE	bronchial:	n/a
10	chr12:316456-316506	NT2-D1	testis:	n/a
11	chr12:313104-313154	SKMC	muscle:	n/a
12	chr12:316456-316506	SK-N-SH	brain:	n/a
13	chr12:295951-296001	NH-A	brain:	n/a
14	chr12:296473-296523	PrEC	prostate:	n/a
15	chr12:296540-296590	NH-A	brain:	n/a
16	chr12:308821-308871	HNPCEpiC	eye:	n/a
17	chr12:312595-312645	A549	lung:	n/a
18	chr12:286620-286670	SK-N-MC	brain:	n/a
19	chr12:313104-313154	MCF-7	breast:	n/a
20	chr12:285704-285754	BE2_C	brain:	n/a
21	chr12:299649-299699	A549	lung:	n/a
22	chr12:301498-301548	AoSMC	blood vessel:	n/a
23	chr12:301498-301548	AG04450	lung:	fetal
24	chr12:286620-286670	NB4	blood:	n/a
25	chr12:298151-298201	PANC-1	pancreas:	n/a
26	chr12:299649-299699	U87	brain:	n/a
27	chr12:297831-297881	HIPEpiC	eye:	n/a
28	chr12:295951-296001	HUVEC	blood vessel:	n/a
29	chr12:291668-291718	SK-N-SH	brain:	n/a
30	chr12:299649-299699	AG10803	skin:	n/a
31	chr12:313104-313154	GM06990	blood:	n/a
32	chr12:316456-316506	T-47D	breast:	n/a
33	chr12:296609-296659	HEEpiC	esophagus:	n/a
34	chr12:301498-301548	T-47D	breast:	n/a
35	chr12:296473-296523	GM06990	blood:	n/a
36	chr12:296540-296590	HMEC	breast:	n/a
37	chr12:298378-298428	GM06990	blood:	n/a
38	chr12:296540-296590	ovcar-3	ovarian:	n/a
39	chr12:298378-298428	GM12878	blood:	n/a
40	chr12:298151-298201	HepG2	liver:	n/a
41	chr12:312595-312645	HNPCEpiC	eye:	n/a
42	chr12:298151-298201	NT2-D1	testis:	n/a
43	chr12:297356-297406	BJ	skin:	n/a
44	chr12:295951-296001	AG09309	skin:	n/a
45	chr12:297831-297881	AG09309	skin:	n/a
46	chr12:298484-298534	HL-60	blood:	n/a
47	chr12:298378-298428	T-47D	breast:	n/a
48	chr12:300298-300348	HEK293	kidney:	embryo
49	chr12:299649-299699	LNCaP	prostate:	n/a
50	chr12:298268-298318	MCF-7	breast:	n/a

(count:24 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr12:297600..300406-chr12:301338..304265,4	K562	blood:
2	chr12:311759..314778-chr12:317325..320101,3	MCF-7	breast:
3	chr12:287241..288955-chr12:290597..292679,2	MCF-7	breast:
4	chr12:308043..310053-chr12:310352..312706,2	MCF-7	breast:
5	chr12:313171..315687-chr12:321794..324554,2	K562	blood:
6	chr12:211691..214245-chr12:294558..297175,2	K562	blood:
7	chr12:316788..319750-chr12:320209..321794,2	K562	blood:
8	chr12:308043..310053-chr12:310352..312706,2	MCF-7	breast:
9	chr12:284257..286850-chr12:289241..291499,2	MCF-7	breast:
10	chr12:297600..300406-chr12:301639..304265,3	K562	blood:
11	chr12:303209..305233-chr12:388816..390804,2	K562	blood:
12	chr12:312121..313775-chr12:317297..318932,2	K562	blood:
13	chr12:309101..311206-chr12:317148..318705,2	K562	blood:
14	chr12:309101..311206-chr12:317148..318705,2	K562	blood:
15	chr12:311562..313775-chr12:316272..318932,2	K562	blood:
16	chr12:298095..299012-chr12:328485..329986,6	MCF-7	breast:
17	chr12:297965..298734-chr12:308100..308686,2	MCF-7	breast:
18	chr12:284226..286607-chr12:303579..306228,2	K562	blood:
19	chr12:296668..298848-chr12:310032..311975,2	K562	blood:
20	chr12:277748..279992-chr12:305232..307484,2	MCF-7	breast:
21	chr12:287922..289463-chr12:291196..293394,2	K562	blood:
22	chr12:311759..314778-chr12:317325..320101,3	MCF-7	breast:
23	chr12:297943..299013-chr12:328724..329295,3	K562	blood:
24	chr12:301002..302613-chr12:305489..307990,2	MCF-7	breast:

(count:11 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-IQSEC3-1	chr12:303127-303296	ENSG00000255671.1
2	lnc-IQSEC3-2	chr12:313184-313395	ENSG00000256577.1
3	lnc-IQSEC3-2	chr12:313806-314189	ENSG00000256577.1
4	lnc-CCDC77-4	chr12:287177-287620	NONHSAT025309
5	lnc-IQSEC3-1	chr12:302202-302346	ENSG00000255671.1
6	lnc-IQSEC3-2	chr12:313806-314228	NONHSAT025315
7	lnc-SLC6A12-1	chr12:291234-291562	ENSG00000256540
8	lnc-IQSEC3-2	chr12:313033-313411	NONHSAT025315
9	lnc-SLC6A12-1	chr12:291234-291565	ENSG00000256540
10	lnc-IQSEC3-2	chr12:312808-312905	ENSG00000256577.1
11	lnc-CCDC77-4	chr12:285648-285729	NONHSAT025309

No data

Variant related genes	Relation type
ENSG00000256540	TF binding region
SLC6A12	TF binding region
ENSG00000255671	TF binding region
ENSG00000256577	TF binding region
IQSEC3	TF binding region
ENSG00000256540	CpG island
SLC6A12	CpG island
ENSG00000255671	CpG island
ENSG00000256577	CpG island
IQSEC3	CpG island
ENSG00000120645	chromatin interactions
ENSG00000256577	chromatin interactions
ENSG00000255671	chromatin interactions
ENSG00000256540	chromatin interactions
ENSG00000111181	chromatin interactions

Extended variants
information (count: 1918 )
Associated
traits (count: 81 )

Variant overlapped rSNPs/rCNVs (count:1918 , 50 per page) page: 1 2 3 4 5 6 7 ... 39

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs216231	chr12:285110-285111	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs568628525	chr12:285129-285130	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
3	rs548560895	chr12:285131-285132	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
4	rs570254920	chr12:285133-285134	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
5	rs537792672	chr12:285156-285157	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
6	rs184507489	chr12:285162-285163	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
7	rs546018766	chr12:285224-285225	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs571061581	chr12:285238-285239	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs534870297	chr12:285307-285308	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs533786850	chr12:285316-285317	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs397851191	chr12:285323-285324	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs189808375	chr12:285328-285329	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs376156491	chr12:285340-285341	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs564700637	chr12:285367-285368	Bivalent Enhancer Weak transcription Enhancers Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs181406555	chr12:285444-285445	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs574162247	chr12:285451-285452	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs146355193	chr12:285479-285480	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs186216140	chr12:285492-285493	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs138970956	chr12:285512-285513	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs531955406	chr12:285525-285526	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs77059703	chr12:285526-285527	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs557746098	chr12:285537-285538	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs573015840	chr12:285581-285582	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs540394090	chr12:285704-285705	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	lncRNA	n/a	Overlapped CNVs	n/a
25	rs550400686	chr12:285712-285713	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	lncRNA	n/a	Overlapped CNVs	n/a
26	rs559895357	chr12:285722-285723	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	lncRNA	n/a	Overlapped CNVs	n/a
27	rs191336346	chr12:285723-285724	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	lncRNA	n/a	Overlapped CNVs	n/a
28	rs141391156	chr12:285726-285727	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	lncRNA	n/a	Overlapped CNVs	n/a
29	rs528965701	chr12:285730-285731	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
30	rs34610442	chr12:285758-285759	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
31	rs530794499	chr12:285783-285784	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
32	rs147254614	chr12:285787-285788	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
33	rs541946363	chr12:285790-285791	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
34	rs370243263	chr12:285801-285802	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs377551118	chr12:285804-285805	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs370825772	chr12:285838-285839	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs117285284	chr12:285864-285865	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs79524446	chr12:285894-285895	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs528678730	chr12:285910-285911	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs116609263	chr12:285938-285939	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs112144171	chr12:285946-285947	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs529249528	chr12:285956-285957	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs567819405	chr12:285974-285975	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs535221779	chr12:285988-285989	Enhancers Weak transcription Bivalent Enhancer Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs556771978	chr12:286015-286016	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
46	rs568862842	chr12:286023-286024	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
47	rs548510900	chr12:286024-286025	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
48	rs558049006	chr12:286065-286066	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
49	rs547794112	chr12:286088-286089	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a
50	rs573134391	chr12:286119-286120	Enhancers Weak transcription Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:81)

Disease	PMID	Source
Cancer	20164920	CNVD
Myelofibrosis	22110671	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD
Glaucoma	21310917	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Malignant peripheral nerve sheath tumor	19844265	CNVD
Squamous cell cancer	19607727	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Mental retardation	17847001	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
abnormal development	18461090	CNVD
Ovarian cancer	20844748	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Medulloblastoma	16968546	CNVD
Ovine squamous-cell carcinoma	17599052	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Breast cancer	22032731	CNVD
Cancer	21183584	CNVD
Myxofibrosarcoma	16751306	CNVD
Non-small cell lung cancer	21829676	CNVD
Ovarian neoplasms	16753589	CNVD
Prostate cancer	21965145	CNVD
Acute myeloid leukemia	16864856	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Disorders of sex development	21048976	CNVD
Glioblastoma multiforme	21080181	CNVD
Liposarcoma	21253554	CNVD
Prostate cancer	19156837	CNVD
Emphysema	19352772	CNVD
Medulloblastoma	21979893	CNVD
Basal cell lymphoma	17053054	CNVD
Malignant germ cell tumour	17285132	CNVD
Melanoma	18172304	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Wilms tumour	21544195	CNVD
Squamous cell cancer	21044232	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Breast cancer	21264507	CNVD
Cancer	16751803	CNVD
Testicular cancer	18059402	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Seminomas	18059402	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Testicular germ cell tumor	18059402	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
small cell lung cancer	20016488	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Breast cancer	21364760	CNVD
Developmental delay	21147756	CNVD
Acute lymphoblastic leukemia	21248843	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ewing''s sarcoma	17952124	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Acute myeloid leukemia	20729466	CNVD
Breast cancer	21858162	CNVD
Breast cancer	21509527	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21785460	CNVD
Autism	22495309	CNVD
Ovarian cancer	21720365	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:1122 , 50 per page) page: 1 2 3 4 5 6 7 ... 23

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:253800-285600	Weak transcription	Brain Cingulate Gyrus	brain
2	chr12:277200-292800	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
3	chr12:278400-288400	Weak transcription	Fetal Kidney	kidney
4	chr12:279000-285200	Weak transcription	Fetal Thymus	thymus
5	chr12:280000-286000	Weak transcription	Fetal Brain Female	brain
6	chr12:280000-289600	Enhancers	Right Ventricle	heart
7	chr12:280400-286000	Bivalent Enhancer	Placenta	Placenta
8	chr12:280600-287400	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
9	chr12:280600-288000	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
10	chr12:281000-290000	Enhancers	Left Ventricle	heart
11	chr12:281800-285400	Weak transcription	Hela-S3	cervix
12	chr12:281800-289000	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
13	chr12:282000-285400	Weak transcription	Gastric	stomach
14	chr12:282000-286600	Enhancers	Fetal Muscle Leg	muscle
15	chr12:282200-288000	Weak transcription	H1 Cell Line	embryonic stem cell
16	chr12:282600-285400	Weak transcription	Duodenum Smooth Muscle	Duodenum
17	chr12:282600-285600	Weak transcription	Lung	lung
18	chr12:282800-285200	Weak transcription	Sigmoid Colon	Sigmoid Colon
19	chr12:282800-288000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
20	chr12:282800-291200	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
21	chr12:283000-285800	Weak transcription	Primary monocytes fromperipheralblood	blood
22	chr12:283000-287800	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
23	chr12:283000-289400	Enhancers	Fetal Heart	heart
24	chr12:283200-285800	Weak transcription	HUES6 Cell Line	embryonic stem cell
25	chr12:283200-287600	Enhancers	HSMMtube	muscle
26	chr12:283400-286200	Enhancers	Liver	Liver
27	chr12:283400-288400	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
28	chr12:283400-290000	Enhancers	Brain Inferior Temporal Lobe	brain
29	chr12:283600-285400	Weak transcription	Primary hematopoietic stem cells short term culture	blood
30	chr12:283600-287000	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
31	chr12:283600-288200	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
32	chr12:283600-290000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
33	chr12:283800-286600	Enhancers	Fetal Muscle Trunk	muscle
34	chr12:283800-286800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
35	chr12:283800-286800	Enhancers	HSMM	muscle
36	chr12:284000-286800	Enhancers	Duodenum Mucosa	Duodenum
37	chr12:284000-288400	Weak transcription	Primary hematopoietic stem cells	blood
38	chr12:284200-286800	Enhancers	Fetal Intestine Small	intestine
39	chr12:284200-292000	Enhancers	Right Atrium	heart
40	chr12:284200-292600	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
41	chr12:284400-285400	Enhancers	Rectal Mucosa Donor 31	rectum
42	chr12:284400-287000	Enhancers	NHLF	lung
43	chr12:284400-288600	Enhancers	Brain Dorsolateral Prefrontal Cortex	brain
44	chr12:284600-285400	Weak transcription	Psoas Muscle	Psoas
45	chr12:284800-285200	Weak transcription	Esophagus	oesophagus
46	chr12:284800-285800	Weak transcription	Brain Angular Gyrus	brain
47	chr12:284800-285800	Weak transcription	Brain Hippocampus Middle	brain
48	chr12:284800-286200	Enhancers	Stomach Mucosa	stomach
49	chr12:285000-285200	Flanking Bivalent TSS/Enh	Skeletal Muscle Male	skeletal muscle
50	chr12:285000-285200	Enhancers	Spleen	Spleen

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links